Article 22 Blinded In Silico Drug Trial Reveals the Minimum Set of Ion Channels for Torsades de Pointes Risk Assessment

Blinded in silico drug trial reveals the minimum set of ion channels for torsades de pointes risk assessment. Zhou X, Qu Y, Passini E, Bueno-Orovio A, Liu Y, Vargas H, Rodriguez B. Frontiers in Pharmacology. 2020. 10:1643. Partner involved: UOXF